Effects of Propofol and Sevoflurane on Blood Folic Acid and Homocysteine Concentrations in Children

Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03595163
Collaborator
(none)
80
1
2
9.9
8.1

Study Details

Study Description

Brief Summary

To investigate the effect of sevoflurane and propofol on the concentrations of serum homocysteine and folic acid in children who received cochlear implant surgery.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

This study is a prospective single center, cross-reference clinical application study.This study plan to enroll 40 children with cochlear implant surgery. Children were selected randomly and divided into 2 groups.Each group has 20 patients. All children undergo orotracheal intubation, mechanical ventilation will given by anaesthetic machine (U.S. Ohmeda advance cs2 ) to maintain oxygen saturation above 95%, hemodynamics and other vital signs were monitored with the anesthesia monitor.In the operation room,2-3ml arterial blood will be taken.And the levels of homocysteine and folic acid will be measured at week 1.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Effects of Propofol and Sevoflurane on Blood Folic Acid and Homocysteine Concentrations in Children With Cochlear Implant Surgery
Actual Study Start Date :
Jan 1, 2018
Actual Primary Completion Date :
Apr 30, 2018
Anticipated Study Completion Date :
Oct 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group S

Children aged 1 month to 3 years who were scheduled to undergo cochlear implant surgery under general anesthesia were enrolled in this study.Children were treated with an infusion bolus of 2.0mg/kg propofol during anesthesia induction and maintained with 2.0-2.5vol% sevoflurane, with the dosage adjusted to achieve loss of consciousness.The bispectral index of EEG was maintained between 50 and 60 in all groups.The homocysteine and folic acid concentrations were measured after anesthesia induction and at the end of surgery separately .

Drug: Sevoflurane
After anesthesia induction and at the end of the operation, all patients were taken 2-3ml arterial blood respectively.The blood was put at normal temperature for 30 minutes.Then the serum was centrifuged to measure the homocysteine and folic acid concentrations.
Other Names:
  • Blood Folic Acid and Homocysteine Concentrations
  • Active Comparator: Group P

    Children aged 1 month to 3 years who were scheduled to undergo cochlear implant surgery under general anesthesia were enrolled in this study.Children were treated with an infusion bolus of 2.0mg/kg propofol during anesthesia induction and continuous infusion of 7 to 8mg/kg/hour, with the dosage adjusted to achieve loss of consciousness.The bispectral index of EEG was maintained between 50 and 60 in all groups.The homocysteine and folic acid concentrations were measured after anesthesia induction and at the end of surgery separately .

    Drug: Propofol
    After anesthesia induction and at the end of the operation, all patients were taken 2-3ml arterial blood respectively.The blood was put at normal temperature for 30 minutes.Then the serum was centrifuged to measure the homocysteine and folic acid concentrations.
    Other Names:
  • Blood Folic Acid and Homocysteine Concentrations
  • Outcome Measures

    Primary Outcome Measures

    1. Serum folate levels [Measured at Week 1]

      The serum folate concentration was detected by microparticle enzyme immunoassay.

    Secondary Outcome Measures

    1. Plasma homocysteine levels [Measured at Week 1]

      The serum homocysteine concentration was detected by fluorescence polarization immunoassay.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Month to 3 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • children accepted cochlear implant surgery under general anesthesia

    • no participate in any other trial up to 3 months before this study

    • no acute infectious diseases, systemic diseases

    • willing to participate in this study and sign the informed consent

    Exclusion Criteria:
    • unwilling to participate in this study

    • with a history of serious liver or kidney dysfunction

    • hemodynamic instability (etc. shock, blood pressure reduced by 30%)

    • children with egg milk allergy

    • children with a family history of malignant hyperthermia

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Shanghai ninth people's hospital Shanghai China

    Sponsors and Collaborators

    • Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

    Investigators

    • Study Director: Jiang Hong, Ph.D, Shanghai9 hospital
    • Study Chair: Li Jingjie, Ph.D, Shanghai9 hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Jingjie Li, vice-director, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
    ClinicalTrials.gov Identifier:
    NCT03595163
    Other Study ID Numbers:
    • 2018-121-T99
    First Posted:
    Jul 23, 2018
    Last Update Posted:
    Jul 23, 2018
    Last Verified:
    Jul 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jingjie Li, vice-director, Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 23, 2018